Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 2/20 | 0.30 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1914312 | 0.83 | ALDH1A1 (0.36) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL1155729 | 0.77 | MEN1 (0.42) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL9437113 | 0.75 | KMT2A (0.38) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL30612351 | 0.71 | SLC6A2 (0.39) | KDM1A | |
| SCHEMBL20551403 | 0.69 | CES2 (0.40) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL166430 | 0.69 | CES2 (0.40) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL10750072 | 0.68 | CES2 (0.42) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL9347326 | 0.68 | CES2 (0.42) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL13278755 | 0.66 | CES2 (0.41) | MEN1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL3792679 | 0.66 | HSD17B10 (0.33) | HIF1AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475288-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | Richter Gedeon Nyrt. (HU) | 2019-05-01 | — | — | EP | claimed |
| WO-2017221187-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | RICHTER GEDEON NYRT. (HU) | 2017-12-28 | — | — | WO | claimed |
| WO-2012052788-A1 | METHOD FOR PREPARING PHARMACEUTICALLY ACTIVE INGREDIENT AND INTERMEDIATES THEREOF | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2012-04-26 | — | — | WO | claimed |
| EP-3475288-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | Richter Gedeon Nyrt. (HU) | 2019-05-01 | — | — | EP | disclosed |
| WO-2017221187-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | RICHTER GEDEON NYRT. (HU) | 2017-12-28 | — | — | WO | disclosed |
| WO-2014114964-A2 | IMPROVED PROCESS FOR THE PREPARATION OF PRASUGREL AND INTERMEDIATE THEREOF | EGIS PHARMACEUTICALS PUBLIC LIMITED COMPANY (HU) | 2014-07-31 | — | — | WO | disclosed |
| EP-2588483-A1 | IMPROVED PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND | EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság (HU) | 2013-05-08 | — | — | EP | disclosed |
| EP-2516447-A1 | PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS | Egis Gyógyszergyár Nyilvánosan Müködö Részvénytársaság (HU) | 2012-10-31 | — | — | EP | disclosed |
| EP-2499147-A2 | IMPROVED PROCESSES FOR PREPARING PRASUGREL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEROEOF | MSN Laboratories Limited (IN) | 2012-09-19 | — | — | EP | disclosed |
| WO-2012052788-A1 | METHOD FOR PREPARING PHARMACEUTICALLY ACTIVE INGREDIENT AND INTERMEDIATES THEREOF | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2012-04-26 | — | — | WO | disclosed |
| WO-2011077174-A1 | PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS AND INTERMEDIATE COMPOUNDS | EGIS GYÓGYSZERGYÁR NYILÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011077173-A1 | IMPROVED PROCESS FOR PREPARING A PHARMACEUTICAL COMPOUND | EGIS GYÓGYSZERGYÁR NYILÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011042918-A2 | NOVEL AND IMPROVED PROCESSES FOR THE PREPARATION OF PRASUGREL, ITS INTERMEDIATES AND PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES LIMITED (IN) | 2011-04-14 | — | — | WO | disclosed |
| EP-2242736-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL I NTERM EDIATES | Egis Gyógyszergyár Nyilvánosan Müködö Részvénytársaság (HU) | 2010-10-27 | — | — | EP | disclosed |
| WO-2009068924-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL I NTERM EDIATES | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MÜKÖDÖ (HU) | 2009-06-04 | — | — | WO | disclosed |